Cargando…
GLP-1 Receptor Agonists, the Holy Grail Preventing Atrial Fibrillation in Patients With T2D?
[Figure: see text]
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504427/ https://www.ncbi.nlm.nih.gov/pubmed/37719426 http://dx.doi.org/10.1016/j.jacbts.2023.03.022 |
_version_ | 1785106719844597760 |
---|---|
author | Stoll, Lisa Lo, James C. |
author_facet | Stoll, Lisa Lo, James C. |
author_sort | Stoll, Lisa |
collection | PubMed |
description | [Figure: see text] |
format | Online Article Text |
id | pubmed-10504427 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-105044272023-09-17 GLP-1 Receptor Agonists, the Holy Grail Preventing Atrial Fibrillation in Patients With T2D? Stoll, Lisa Lo, James C. JACC Basic Transl Sci Original Research - Preclinical [Figure: see text] Elsevier 2023-08-28 /pmc/articles/PMC10504427/ /pubmed/37719426 http://dx.doi.org/10.1016/j.jacbts.2023.03.022 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Research - Preclinical Stoll, Lisa Lo, James C. GLP-1 Receptor Agonists, the Holy Grail Preventing Atrial Fibrillation in Patients With T2D? |
title | GLP-1 Receptor Agonists, the Holy Grail Preventing Atrial Fibrillation in Patients With T2D? |
title_full | GLP-1 Receptor Agonists, the Holy Grail Preventing Atrial Fibrillation in Patients With T2D? |
title_fullStr | GLP-1 Receptor Agonists, the Holy Grail Preventing Atrial Fibrillation in Patients With T2D? |
title_full_unstemmed | GLP-1 Receptor Agonists, the Holy Grail Preventing Atrial Fibrillation in Patients With T2D? |
title_short | GLP-1 Receptor Agonists, the Holy Grail Preventing Atrial Fibrillation in Patients With T2D? |
title_sort | glp-1 receptor agonists, the holy grail preventing atrial fibrillation in patients with t2d? |
topic | Original Research - Preclinical |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504427/ https://www.ncbi.nlm.nih.gov/pubmed/37719426 http://dx.doi.org/10.1016/j.jacbts.2023.03.022 |
work_keys_str_mv | AT stolllisa glp1receptoragoniststheholygrailpreventingatrialfibrillationinpatientswitht2d AT lojamesc glp1receptoragoniststheholygrailpreventingatrialfibrillationinpatientswitht2d |